Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_assertion type Assertion NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_head.
- NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_assertion wasGeneratedBy ECO_0000203 NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_provenance.
- NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_assertion wasDerivedFrom befree-2016 NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_provenance.
- NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_assertion SIO_000772 14557375 NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_provenance.
- NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_assertion evidence source_evidence_literature NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_provenance.
- NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_assertion description "[These studies support the ability of anthracyclines to activate antiapoptotic p44/42-MAPK phosphorylation in breast cancer, and indicate that this occurs in part through the novel mechanism of repression of MKP-1 transcription.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416713.RAwnijA3Pb2E_tujnLAc2uVUwYc3SDvZDyZE4zw6tddzM130_provenance.